echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Summary table of lung cancer, targeted and immunotherapy drugs (January 2022)

    Summary table of lung cancer, targeted and immunotherapy drugs (January 2022)

    • Last Update: 2022-01-08
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    At the end of 2021, the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2021)" was announced.
    The new version of the medical insurance catalog has been officially launched nationwide on January 1, 2022
    .


    In the latest medical insurance catalogue in 2021, a variety of anti-tumor drugs are newly included, covering a wide range, including non-small cell lung cancer, lymphoma, breast cancer, ovarian cancer, liver cancer, gastric cancer, myeloma, prostate cancer, neuroendocrine tumors, etc.


    The editor compiled more than 40 drugs approved by the FDA and NMPA and recommended by NCCN guidelines in the field of lung cancer targeted and immunotherapy (as of December 2021), and attached relevant information such as medical insurance payment prices and medical insurance indications
    .


    For everyone to see!

    Non-small cell lung cancer

    Non-small cell lung cancer

    Small Cell Lung Cancer

    Remark:

    1.


    2.


    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.